Answers are grounded in this paper and cite their sources.
Key points(1) A wide array of data regarding acute migraine treatment are available, but few trials strictly adhere to International Headache Society guidelines for patient inclusion criteria.(2) Triptans appear to have similar efficacy profiles, but among newer triptans, almotriptan offers improved
No takes yet. Share an insight, caveat, or question.
Mett et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: